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Abstract
Peroxynitrite is usually considered as a neurotoxic nitric oxide-
derivative. However, an increasing body of evidence suggests
that, at low concentrations, peroxynitrite affords transient cy-
toprotection, both in vitro and in vivo. Here, we addressed the
signaling mechanism responsible for this effect, and found that
rat cortical neurons in primary culture acutely exposed to
peroxynitrite (0.1 mmol/L) rapidly elicited Akt-Ser473 phos-
phorylation. Inhibition of phosphoinositide-3-kinase (PI3K)/Akt
pathway with wortmannin or Akt small hairpin RNA (shRNA)
abolished the ability of peroxynitrite to prevent etoposide-in-
duced apoptotic death. Endogenous peroxynitrite formation by
short-term incubation of neurons with glutamate stimulated
Akt-Ser473 phosphorylation, whereas Akt shRNA enhanced
the vulnerability of neurons against glutamate. We further
show that Akt-Ser473 phosphorylation was consequence of the
oxidizing, but not the nitrating properties of peroxynitrite. Per-
oxynitrite failed to nitrate or phosphorylate neurotrophin tyro-
sine kinase receptors (Trks), and it did not modify the ability of
brain-derived neurotrophic factor (BDNF), to phosphorylate
its cognate receptor, TrkB; however, peroxynitrite enhanced
BDNF-mediated Akt-Ser473 phosphorylation. Finally, we found
that peroxynitrite-stimulated Akt-Ser473 phosphorylation
was associated with an increased proportion of oxidized
phosphoinositide phosphatase, PTEN, in neurons. Moreover,
peroxynitrite prevented the increase of apoptotic neuronal
death caused by over-expression of PTEN. Thus, peroxynitrite
exerts neuroprotection by inhibiting PTEN, hence activating
the anti-apoptotic PI3K/Akt pathway in primary neurons.
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Peroxynitrite (PN), the product of the reaction between nitric
oxide (NO) and superoxide (O2
•)) (Blough and Zafiriou
1985), is spontaneously formed in mammalian cells under
physiological conditions (Radi et al. 2001; Possel et al.
2002). Initial work addressing the pathophysiology of PN
yielded the widely accepted notion that this compound would
be the long-term cytotoxic NO-derivative (Beckman et al.
1990; Radi et al. 1991). Peroxynitrite involvement in
cytotoxicity is documented by detecting protein 3-nitroty-
rosination, i.e. the ‘footprinting’ like evidence for in situ PN
formation (Ischiropoulos et al. 1992; Greenacre and Ischi-
ropoulos 2001; Beal 2002), associated with neurodegenera-
tion and other disorders (Bolan˜os et al. 1997; Lipton 1999;
Guix et al. 2005). However, in apparent contradiction with
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this notion, it has been shown that contractile failure (Lefer
et al. 1997), arrhythmias (Altug et al. 1999) or necrosis
(Nossuli et al. 1997, 1998) provoked by ischemia-reper-
fusion in the rat heart in vivo can be abolished by infusion
with PN. Moreover, we previously showed that pre-treatment
of primary neurons in culture with PN exerts transient
neuroprotection against acute oxidative stress (Garcia
Nogales et al. 2003).
These lines of evidence have raised the question of
whether PN plays an active role in the etiology of
neurodegenerative diseases, or its formation would be an
emergency signal aimed at avoiding cellular death during
oxidative insults (Ferdinandy and Schulz 2003; Bolan˜os
et al. 2004). In fact, PN rapidly stimulates, in neurons, the
activity of glucose-6-phosphate dehydrogenase (Garcia
Nogales et al. 2003), the enzyme catalyzing the rate-
limiting step of the pentose-phosphate pathway. Neurons
can thus improve the capacity to regenerate glutathione
(Garcia Nogales et al. 2003) – the antioxidant whose
deficiency contributes to mitochondrial damage and apop-
tosis associated with certain neurodegenerative diseases
(Bolan˜os et al. 1996; Jha et al. 2000; Diaz-Hernandez et al.
2005). Whilst such an antioxidant defense mechanism
renders neurons more resistant to early cellular oxidation, it
remains unclear whether PN would stimulate long-lasting
signaling pathway(s) aimed at avoiding the propagation of
neurodegeneration.
Previous work performed in other laboratories using
skin fibroblasts has reported that PN can cooperate or interfere
with tyrosine kinase receptor-mediated signaling pathways
(Klotz et al. 2002; So¨ylemez et al. 2003). Peroxynitrite has
been shown to oxidize – and thus inhibit – cysteinyl residue(s)
of the protein tyrosine phosphatase (PTP) (Mallozzi et al.
1997; Takakura et al. 1999), leading to inhibition of tyrosine
kinase receptor dephosphorylation (Mallozzi et al. 1997;
Klotz et al. 2002). However, pre-treatment of skin fibroblast
with PN, far from stimulating, attenuated PDGF-induced
protein kinase B (Akt) phosphorylation (Klotz et al. 2000).
Thus, the results obtained so far appear rather confusing
(Bolan˜os et al. 2004), a fact that has prevented researchers
from postulating a valid signaling mechanism that would be
responsible for the neuroprotection afforded by PN.
Here, we aimed to investigate the involvement of the
anti-apoptotic phosphoinositide-3-kinase (PI3K)/Akt signa-
ling pathway in PN-mediated neuroprotection in rat cortical
primary neurons. We demonstrate that PN affords neuropro-
tection by promoting Akt-Ser473 phosphorylation. Further-
more, we show that this effect is due to inhibition – by
oxidation – of 3-phosphoinositide 3-phosphatase with tensin
homology (PTEN), but not to modification of Trk receptors.
These results suggest that caution should be taken when
considering PN scavengers as neuroprotectants, and highlight
the potential benefits of PTEN interference against neuro-
degeneration.
Materials and methods
Reagents
Dulbecco’s modified Eagle’s medium (DMEM), poly-D-lysine,
horse serum, cytosine arabinoside, ())epicatechin, etoposide,
N-ethylmaleimide (NEM), hydrogen peroxide, glutathione ethyl
ester (GSH), glutamate, and glycine were obtained from Sigma
Chemical Co. (St Louis, MO, USA). DMEM was supplemented
with penicillin (100 U/mL), streptomycin (100 lg/mL) and amph-
otericin B (0.25 lg/mL) (Sigma), except where indicated. Fetal
bovine serum (FBS) was purchased from Roche Diagnostics
(Heidelberg, Germany). Brain-derived neurotrophic factor (BDNF)
was obtained from Peprotech EC (London, UK). Hybond
nitrocellulose membranes were from Amersham Biosciences
(Buckinghamshire, UK). Plastic tissue culture dishes were pur-
chased from Nunc (Roskilde, Denmark). Lipofectamine-2000 was
purchased from Invitrogen (Groningen, The Netherlands). 2¢,7¢-
Dichlorodihydrofluorescin diacetate (H2DCFDA) was obtained
from Molecular Probes (Invitrogen). The PN donor 3-morpholino-
sydnonimine (SIN-1) was purchased from Alexis Corp. (San Diego,
CA, USA). Other substrates, inhibitors, enzymes, and coenzymes
were purchased from Sigma, Roche Diagnostics, Promega Biotech
(Madrid, Spain), Pharmacia or Merck (Darmstadt, Germany).
Design of shRNAs for Akt1/2
Akt1/2 knockdown was achieved by RNA interference using a
vector-based shRNA approach (Brummelkamp et al. 2002). The
shRNA-targeted cDNA sequence was chosen to knockdown Akt1
and Akt2 from either human and rat. The selected sequence was
5¢-GTGGTCATGTACGAGATGA-3¢ [corresponding to nt. 1207–
1225 (NM_005163, human Akt1), 1215–1233 (NM_001626,
human Akt2), 1051–1069 (NM_033230, rat Akt1) and 1293–
1311 (NM_017093, rat Akt2)], which was designed according to a
previously reported rational protocol (Reynolds et al. 2004) to
accomplish criteria I, II, III, IV, VI, VII and VIII. As controls,
we used either the firefly luciferase-targeted oligonucleo-
tide 5¢-CTGACGCGGAATACTTCGA-3¢, as previously reported
(Ohtsuka et al. 2004) or a scrambled Akt sequence (5¢-CGTTAC-
ATCACGATCCTAC-3¢). All sequences were BLAST-confirmed
for specificity. The forward and reverse synthetic 64-nt oligonu-
cleotides (Isogen Life Technologies, Maarsen, The Netherlands)
were designed, annealed, and inserted into the BglII/HindIII sites
of the pSuper-neo/green fluorescent protein (GFP) vector, follow-
ing the manufacturer’s instructions (Oligoengine, Seatle, WA,
USA). These constructions express 19 base-pair 9-nt stem-loop
shRNAs targeted against human and rat Akt1/2 (Akt shRNA),
luciferase (used as a shRNA control) or scrambled Akt (used as
another shRNA control) mRNAs. The concomitant expression of
GFP from this vector allowed the identification of transfected cells
by flow cytometry.
Plasmid constructions
The cDNAs encoding wild type and mutated (Cys124 fi Ser124)
PTEN were generous gifts from Prof. R. Pulido (Centro de
Investigacio´n Prı´ncipe Felipe, Valencia, Spain). Both cDNAs were
subcloned into the corresponding EcoRI or BamHI sites of the
pIRES2-EGFP mammalian expression vector (Invitrogen) and
sequenced for confirmation. The concomitant expression of GFP
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from this vector allowed the identification of transfected cells by
flow cytometry.
Neurons in primary culture
Cerebral cortex neurons in primary culture were prepared from fetal
Wistar rats at 16 days of gestation (Almeida et al. 2004). Dissoci-
ated cell suspensions were plated at a density of 2.5 · 105 cells/cm2
in 60 cm2 Petri dishes, or 6- or 12-wells plates, previously coated
with poly-D-lysine (15 lg/mL) in DMEM supplemented with 10%
fetal calf serum. Cells were incubated at 37C in a humidified
atmosphere containing 5% CO2/95% air. Forty-eight hours after
plating, the medium was replaced with DMEM supplemented with
5% horse serum, 20 mmol/L D-glucose and cytosine arabinoside
(10 lmol/L) to prevent non-neuronal proliferation. Neurons, which
were approximately 99% Map2-positive, were transfected on day 4
(for Akt knockdown) or 6 (for PTEN expression).
HEK293T cells
Human embryonic kidney 293T (HEK293T) cells were maintained
in DMEM supplemented with 10% (v/v) fetal calf serum. Cells were
re-seeded at 105 cells/cm2 1 day before transfections.
Synthesis of peroxynitrite
Peroxynitrite was synthesized and quantified spectrophotometrically
(e302 = 1670/M/cm) as previously described (Hughes and Nicklin
1968). Alkaline stock solutions, with an approximate PN concen-
tration of 0.5 mol/L, were stable at )70C for at least 3–4 months.
Cell treatments
Cell transfections were performed with pSuper-neo/gfp- or pIRES2-
EGFP-derived plasmid constructions using Lipofectamine 2000
(Invitrogen), following the manufacturer’s instructions. After 6 h,
the medium was removed and cells were further incubated for the
indicated time periods in complete culture medium. Peroxynitrite
was added to neurons in boli of 50, 100 or 500 lmol/L (final
concentration) from 500-fold concentrated stock solutions in
buffered Hanks’ solution (5.26 mmol/L KCl, 0.43 mmol/L
KH2H2PO4, 132.4 mmol/L NaCl, 4.09 mmol/L NaHCO3,
0.33 mmol/L Na2HPO4, 20 mmol/L glucose, 2 mmol/L CaCl2,
and 20 mmol/L HEPES, final pH 7.4); the corresponding control
incubations consisted of previously degraded (for 3 h at 37C) PN
solutions. Owing to the relative instability of authentic PN solutions
at physiological pH, neurons were also incubated, for 15 min, in
DMEM containing SIN-1, a PN source formed from nitric oxide and
superoxide (Feelisch et al. 1989; Schrammel et al. 1998). Prelim-
inary experiments using a NO-sensitive electrode (ISO-NO) (not
shown) suggested an approximate PN formation from SIN-1
(0.5 mmol/L) of about 10 lmol/L, as previously reported (Schram-
mel et al. 1998). To ensure immediate maximum PN release from
SIN-1, all SIN-1-containing solutions were always pre-incubated in
DMEM at 37C for 20 min before the addition to the cells. SIN-1
controls experiments were performed using a degraded SIN-1
solution (72 h at 37C). To activate glutamate receptors thus
promoting the endogenous formation of PN (Almeida and Bolan˜os
2001), neurons were incubated, for 5 min, with 100 lmol/L
glutamate (plus 10 lmol/L glycine) in buffered Hanks’ solution
(pH 7.4), either in the absence or in the presence of wortmannin
(100 nmol/L), GSH (5 mmol/L) or superoxide dismutase (SOD)
plus catalase (CAT) (100 U/mL each). Neurons were then washed
and further incubated in culture medium for the indicated time
period. To ensure a low degree of phosphorylation of Trk receptor
and Akt in the controls, all experiments were carried out in neurons
pre-incubated in serum-free DMEM for 6 h. Experiments combi-
ning PN and BDNF were performed as follows: neurons were
incubated (in buffered Hanks’ solution.) for 5 min with PN
(100 lmol/L, or its degraded solution as control) followed by a
further 5 min incubation in the absence or presence of BDNF
(50 ng/mL); alternatively, neurons were incubated for 5 min in the
absence or presence of BDNF (50 ng/mL) followed by a further
5 min incubation with PN (100 lmol/L or its degraded solution as
control).
Western blotting
Cells were lysed for 20 min at 4C in a buffer containing 1%
nonidet NP-40, 5 mmol/L EDTA, 20 mmol/L Tris, pH 8.0,
137 mmol/L NaCl, 10% glycerol, 100 lmol/L phenylmethylsulfo-
nyl fluoride, 50 lg/mL anti-papain, 50 lg/mL pepstatin, 50 lg/mL
amastatin, 50 lg/mL leupeptine, 50 lg/mL bestatin, 1 mmol/L o-
vanadate, and 50 lg/mL soybean trypsin inhibitor. Extracts were
centrifuged at 13 000 g for 20 min at 4C and and aliquots
containing 100 lg of protein from each sample, as determined
extemporarily following the BCATM Protein assay kit (Pierce,
Rockford, IL, USA) using albumin as standard and the Bench-
MarkTM pre-stained protein ladder (Invitrogen), and were subjected
to sodium docedyl sulfate (SDS, 0.1%)-polyacrylamide gel elec-
trophoresis (PAGE) on a 7% (Trk receptors and 3-nitrotyrosine), 8%
(Akt, phospho-Akt) or 10% (PTEN) acrylamide gel (MiniProtean;
Bio-Rad, Hercules, CA, USA). The resolved proteins were trans-
ferred electrophoretically to nitrocellulose membranes (Hybond-
ECL; Amersham Bioscience Europe GmbH, Barcelona, Spain).
Membranes were blocked with 5% (w/v) low-fat milk in 20 mmol/L
Tris, 500 mmol/L NaCl, 0.1% (w/v) Tween-20 (pH 7.5) for 1 h.
Immunoblotting was performed using a-panTrk antibody (Martin-
Zanca et al. 1989), a-phospho-Tyr490-Trk (Cell Signaling Techno-
logy), a-Akt (Cell Signaling Technology), a-phospho-Ser473-Akt
(a-pAkt; Cell Signaling Technology), a-PTEN (421B, a generous
gift from Prof. R. Pulido (Centro de Investigacio´n Prı´ncipe Felipe,
Valencia, Spain) or a-3-nitro-Tyr (a generous gift from Prof. J.
Rodrigo, Instituto Cajal, Madrid, Spain) antibodies. Anti-phospho-
fructokinase-1 (PFK1) was used as loading control (Almeida et al.
2004). Anti-rabbit secondary antibody was from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Membranes were incubated
with horseradish peroxidase-conjugated goat antirabbit IgG
(1 : 10 000; Santa Cruz Biotechnology, Santa Cruz, CA, USA)
and immediately incubated with Supersignal West Dura (Pierce) for
5 min before exposed to Kodak XAR-5 film (Sigma) for 1–3 min.
Autoradiograms were scanned.
Identification of reduced and oxidized forms of PTEN by
immunoblot analysis
This was performed following the method of Lee et al. (2002). In
brief, we followed identical protocol to that for western blotting,
with the exceptions that the buffer contained 40 mmol/L NEM and,
after centrifugation, aliquots were subjected to SDS-PAGE under
reducing (715 mmol/L b-mercaptoethanol) or non-reducing (with-
out b-mercaptoethanol) conditions.
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Slot blotting
This was performed by vacuum-mediated transference of cellular
protein extracts – obtained as indicated for western blotting – to
nitrocellulose membranes, followed by immunoblotting against
a-nitro-Tyr antibody, as indicated in the western blotting section.
Immunoprecipitation
Cells were lysed in a buffer containing 1% Nonidet NP-40,
137 mmol/L NaCl, 20 mmol/L Tris (pH 8.0), 10% glicerol, 5 mmol/
L EDTA, 1 mmol/L sodium orthovanadate, 1 mmol/L phenyl-
methylsulfonyl fluoride, 5 lg/mL leupeptin, 5 lg/mL aprotinin F.
One milligram of protein was incubated with a-pan-Akt in
the presence of 24 lL of protein A-sepharose during 4 h at 4C.
The inmunoprecipitated complex was extensively washed with the
lysing buffer and the mixture was then subjected to SDS-PAGE.
Flow cytometric analysis of apoptotic cell death
Allophycocyanin (APC)-conjugated annexin-V and 7-amino-actino-
mycin D (7-AAD) (Apoptosis Assay Kit; Becton Dickinson
Biosciences, San Jose´, CA, USA) were used to quantitatively
determine the percentage of apoptotic cells by flow cytometry. Cells
were stained with annexin V-APC and 7-AAD, following the
manufacturer’s instructions, and were analysed on a FACScalibur
flow cytometer (15 mW argon ion laser tuned at 488 nm; CellQuest
software, Becton Dickinson Biosciences). Both GFP+ and GFP)
cells were analyzed separately, and the annexin V-APC-stained cells
that were 7-AAD-negative were considered apoptotic (Almeida
et al. 2004).
Analysis of apoptotic death by 4¢-6-diamidino-2-phenylindole
nuclear staining
Neurons were fixed with 4% [v/v, in phosphate-buffered saline
(PBS)] paraformaldehyde for 30 min at 25C, rinsed with PBS
and incubated with 4¢-6-diamidino-2-phenylindole (DAPI)
(30 lmol/L; Sigma). After 10 min, cells were washed three times
with PBS and their nuclei examined under a fluorescence
microscope by an author blinded to the test. A total of
approximately 200 cells per condition in three different cultures
were quantified, and the results were expressed as the percentage
of condensed or fragmented nuclei.
NADPH determination
Neurons were washed with ice-cold PBS and lysed in 0.5 mol/L
KOH in 50% (vol/vol) ethanol. NADPH determination was
performed exactly as previously described (Garcia Nogales et al.
2003).
Immunofluorescence measurement of
dichlorodihydrofluorescein (H2DCFDA) oxidation
Neurons were incubated with 10 lmol/L H2DCFDA in Hanks’
solution (pH 7.4). After 30 min at 37C, cells were washed twice
with PBS and incubated with PN for 5 min in the presence of
varying concentrations of epicatechin (10, 100 or 1000 lmol/L).
Dichlorofluorescein fluorescence was measured in a Fluoroskan
Ascent Fluorimeter (Thermo Electron Corporation, Milford,
MA, USA; excitation at 485 nm, emission at 538 nm) and
expressed in arbitrary units, as previously reported (Wang and
Joseph 1999).
Statistical analysis
Measurements from individual cultures were always performed in
triplicate. The results are expressed as mean ± SEM values for three
different culture preparations. Statistical analysis of the results was
performed by one-way analysis of variance, followed by the least
significant difference multiple range test. In all cases, p < 0.05 was
considered significant.
Results
Peroxynitrite prevents etoposide-mediated apoptotic
death by stimulating the PI3K/Akt pathway in primary
cortical neurons
In a previous study, we demonstrated that PN, applied
either directly or released from the PN donor SIN-1, time-
dependently protected neurons against the apoptotic death
caused by acute oxidative stress (Garcia Nogales et al.
2003). Furthermore, we showed that protection was max-
imal at short-term periods (1–4 h), progressively disappear-
ing thereafter (Garcia Nogales et al. 2003). To explore the
possibility that such protection could be a consequence of
the activation of the anti-apoptotic pathway, phosphoinos-
itide-3-kinase (PI3K)/Akt, we first investigated whether Akt
was phosphorylated by PN treatment. As shown in Fig. 1a
(upper panel), PN rapidly (5 min) triggered Akt phosphory-
lation at Ser473 in a concentration-dependent manner, being
evident at 100 lmol/L. To test whether Akt-Ser473 phos-
phorylation was a consequence of PI3K activity, we used
the PI3K inhibitor, wortmannin. As shown in Fig. 1a (lower
panel), wortmannin (100 nmol/L) efficiently prevented Akt-
Ser473 phosphorylation. Next, we confirmed the neuropro-
tective role of PN and showed that acute incubation of
neurons with a bolus of PN at 100 lmol/L, i.e. the
concentration shown to promote Akt-Ser473 phosphorylation
(Fig. 1a) protected them against the initiation of apoptotic
death caused by etoposide (10 lg/mL; 1 h) (Fig. 1b).
Etoposide was used as the apoptotic death trigger, since
this procedure has been previously validated to be suitable
for the investigation of apoptotic death and neuroprotective
pathways in cortical neurons (Nakajima et al. 1994). Our
results thus suggest that both phenomena – Akt phosphory-
lation and neuroprotection – might be linked. Blockade of
PI3K activity with wortmannin fully abolished the protec-
tion that PN afforded against etoposide-mediated apoptotic
death (Fig. 1b). We further confirmed these results by
determining the proportion of condensed or fragmented
nuclei using DAPI staining (Figs 1c and d). As shown in
Fig. 1d, the increase in apoptotic death triggered by
etoposide as assessed with DAPI was slightly higher than
that using annexin V (Fig. 1b), although PN afforded full
protection (in the absence of wortmannin) regardless of the
method used (Fig. 1d). We next explored whether Akt
phosphorylation could be linked to the increased NADPH
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concentrations by PN that we previously reported (Garcia
Nogales et al. 2003). We found that the increase in
neuronal NADPH concentrations caused by PN was not
impaired by wortmannin (in pmol/mg of protein, degraded
PN, 52 ± 4; 100 lmol/L PN, 120 ± 11; degraded PN +
wortmannin, 55 ± 6; 100 lmol/L PN + wortmannin,
121 ± 10; n = 3), ruling out the involvement of the PI3K/
Akt pathway in this effect.
We next designed a vector-based small hairpin RNA
(shRNA) strategy against Akt to more specifically knock-
down the PI3K/Akt pathway. As shown in Fig. 2a, expres-
sion of a plasmid vector carrying the shRNA Akt sequence
efficiently reduced Akt protein in HEK293T cells 2 days
after transfection. Control transfections were carried out
expressing either a shRNA sequence against luciferase
(shRNA Luc) (Diaz-Hernandez et al. 2005) or a correspond-
ing scrambled Akt sequence. Transfection of neurons in
primary culture with the shRNA Akt only resulted in a low
degree of loss of neuronal survival when compared with the
shRNA Luc or scrambled Akt transfections, at least at the
time when the experiments were performed (3 days after
transfection), although the values did not reach statistical
differences (Fig. 2b). Etoposide triggered a rapid (1 h)
apoptotic response, whereas PN did not. Furthermore, PN
prevented etoposide-mediated apoptotic death in neurons
transfected with the shRNA Luc or scrambled Akt, but not in
those transfected with shRNA Akt (Fig. 2b). These results
further support the essential role of Akt during PN neuro-
protection. We next studied whether Akt silencing abolished
neuroprotection by PN formed from SIN-1, a compound
known to form PN by simultaneously releasing nitric oxide
and superoxide. As shown in Fig. 2c, Akt-Ser473 was
phosphorylated 15 min after incubation with SIN-1, an
effect that was prevented by wortmannin. Furthermore, SIN-
1 prevented etoposide-mediated apoptotic death in neurons
transfected with shRNA Luc, but not in those transfected
with shRNA Akt (Fig. 2d). Next, we incubated neurons with
glutamate (100 lmol/L for 5 min), a treatment that we, and
others, have shown to trigger spontaneous in situ PN
formation (Almeida and Bolan˜os 2001; El-Remessy et al.
2003). We found that glutamate rapidly (5 min) increased
Akt-Ser473 phosphorylation in primary neurons (Fig. 2e),
confirming a previous work (Sutton and Chandler 2002).
Furthermore, this effect was prevented with wortmannin
(Fig. 2e), implicating the PI3K/Akt pathway in the PN-medi-
ated Akt-Ser473 phosphorylation. Long-term (18–24 h)
(a)
(c) (d)
(b)
Fig. 1 Peroxynitrite prevents etoposide-
mediated apoptotic death through phos-
phoinositide-3-kinase (PI3K)/protein kinase
B (Akt) pathway in neurons in primary
culture. (a) Incubation of neurons with
peroxynitrite concentration-dependently
promoted Akt phosphorylation (phospho-
Ser473) after 5 min (upper panel), an effect
that was prevented by wortmannin
(100 nmol/L) (lower panel). (b) Pre-treat-
ment of neurons with 100 lmol/L peroxyni-
trite (5 min) prevented apoptotic death
promoted by etoposide (10 lg/mL) after
1 h, and effect that was abolished by wort-
mannin (100 nmol/L). (c) Typical micro-
photographs showing condensed or
fragmented nuclei by 4¢-6-diamidino-
2-phenylindole staining under identical
conditions as those used for (b). (d) Quan-
tification of the results shown in (c).
*p < 0.05 when compared with the corre-
sponding control (degraded PN) values.
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incubation of neurons after glutamate treatment often causes
neurotoxicity (excitotoxicity) (Dawson et al. 1991; Almeida
and Bolan˜os 2001). In contrast, acute glutamate treatment
(100 lmol/L for 5 min) did not result in short-term (1 h after
glutamate challenge) neurotoxicity (Fig. 2f); however, Akt
silencing with shRNA enhanced apoptotic death (Fig. 2f).
(a) (b)
(c)
(d)
(e)
(f)
Fig. 2 Knockdown of protein kinase B (Akt) by small interfering RNA
abolishes neuroprotection by peroxynitrite and triggers neurotoxicity
by glutamate in neurons in primary culture. (a) To confirm the efficacy
of the designed small hairpin RNA (shRNA), HEK293T cells were
transfected with a pSuper-neo/gfp plasmid vector expressing an
shRNA against Akt, which promoted Akt knockdown 2 days after
transfections, when compared with appropriate controls (shRNA Luc
or shRNA scrambled Akt), as evidenced by western blotting. (b)
Transfection of neurons with shRNA Akt did not cause, after 3 days,
apoptotic death when compared with controls (shRNA Luc or shRNA
scrambled Akt); etoposide triggered apoptotic death in neurons
regardless of Akt expression; incubation of transfected neurons with
peroxynitrite, alone, is not neurotoxic; however, pre-incubation of
neurons with peroxynitrite prevented etoposide-mediated apoptotic
death in controls (shRNA Luc or shRNA scrambled Akt), but not in Akt-
silenced (shRNA Akt) neurons. (c) Incubation of neurons with SIN-1
(0.5 mmol/L) promoted Akt phosphorylation (phospho-Ser473) after
15 min, an effect that was prevented by wortmannin (100 nmol/L). (d)
Incubation of neurons with SIN-1 (0.5 mmol/L), alone, is not neuro-
toxic; however, pre-incubation of neurons with SIN-1 (0.5 mmol/L)
prevented etoposide-mediated apoptotic death in control (shRNA
Luc), but not in Akt-silenced (shRNA Akt) neurons. (e) Incubation of
neurons with glutamate (100 lmol/L, 5 min) triggered Akt phos-
phorylation, an effect that was prevented by wortmannin (100 nmol/L).
(f) Akt knockdown by shRNA in neurons enhanced glutamate-medi-
ated apoptotic death 1 h after treatment, an effect that was prevented
by either glutathione ethyl ester (5 mmol/L) or superoxide dismutase
plus CAT (100 U/mL each). *p < 0.05 when compared with the cor-
responding control values. #p < 0.05 when compared with corre-
sponding glutamate-treated shRNA Akt values. Glu, glutamate; GSH,
glutathione ethyl ester; SOD/CAT, superoxide dismutase plus cata-
lase.
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These results confirm the involvement of the PI3K/Akt
neuroprotective signaling pathway in the short-term incuba-
tion of cortical neurons with glutamate. To ascertain whether
PN was involved in glutamate-mediated neuroprotection,
GSH – a PN scavenger – or SOD/CAT – superoxide and
H2O2 scavengers – were used. The results (Fig. 2f) show that
both treatments significantly prevented shRNA Akt-mediated
apoptotic death in glutamate-treated neurons. In view of the
difficulties to selectively scavenge PN without altering other
potential oxidants within the cell, these results do not
unambiguously determine the involvement of PN in glutam-
ate-mediated short-term neuroprotection. However, these
data clearly indicate that short-term glutamate treatment
activates the PI3K/Akt pathway in primary cortical neurons,
and that this activation is required for PN (and/or a related
oxidant)-mediated neuroprotection.
The phosphorylation of Akt-Ser473 promoted by
peroxynitrite is not mediated through phosphorylation or
nitration of Trk receptors in primary neurons
Cortical neurons express the neurotrophin receptor TrkB, and
are protected form apoptosis by its cognate ligand, BDNF
(Hetman et al. 1999). To try to understand the mechanism
responsible for PN-mediated Ser473-Akt phosphorylation, we
first focused on Trk receptors, since their activation – by
phosphorylation – can stimulate the PI3K/Akt pathway.
Cortical neurons were incubated with PN, alone, or in
combination with BDNF. As shown in Fig. 3a, BDNF
triggered the expected response by rapidly (10 min) promo-
ting the phosphorylation of Trk receptors at Tyr490, hence
confirming the expression of functional TrkB in these cells.
In addition, PN treatment did not elicit Trk phosphorylation
(Fig. 3a). Moreover, pre-treatment of neurons with BDNF
did not affect the response to PN; and, pre-treatment with PN
did not affect the response to BDNF (Fig. 3a). In view that
PN was unable to alter Trk phosphorylation, we next studied
whether it modified Trk receptor nitration, since such
modification has been suggested to occur, at least in other
cellular systems (Bolan˜os et al. 2004). Indeed, PN caused an
increase in overall 3-nitrotyrosination of cell proteins
(Fig. 3b, left panel). To ascertain whether some of these
proteins were Trk receptor(s), we performed immunoprecip-
itation using a pan-Trk antibody, and the precipitated proteins
were subjected to western blotting with a nitro-tyrosine
antibody. As shown in Fig. 3b (right panel), PN did not cause
Trk receptor nitration, as judged by the lack of 3-nitrotyro-
sinated proteins in Trk immunoprecipitates. We next showed
that PN and BDNF-induced Akt phosphorylation were
additive. As shown in Fig. 3c, PN increased the degree of
Ser473-Akt phosphorylation caused by BDNF, and BDNF
increased the degree of Ser473-Akt phosphorylation caused
by PN. These results confirm that PN triggers Akt phos-
phorylation through a mechanism that does not involve Trk
receptors in primary neurons, and suggest that PN and BDNF
activate different signaling pathways that converge in Akt
activation.
Protein oxidation, but not nitration, accounts for
peroxynitrite-mediated neuroprotection and Akt
phosphorylation
Previous studies have demonstrated that PN can alter
protein functions by nitrating or oxidizing critical Tyr
or Cys residues, respectively (Bolan˜os et al. 2004).
Accordingly, we next aimed to investigate whether the
(a)
(b)
(c)
Fig. 3 Phosphorylation of protein kinase B (Akt) by peroxynitrite is
not mediated through phosphorylation or nitration of Trk receptors in
primary neurons. (a) Brain-derived neurotrophic factor (BDNF, 50 ng/
mL), but not peroxynitrite, increased Trk Tyr490 phosphorylation after
5 min of incubation. (b) Peroxynitrite promoted overall protein nitro-
tyrosination (left panel) in neurons, but immunoprecipitation against
Trk receptors revealed that these receptors were not nitrotyrosinated
(right panel). (c) The phosphorylation of Akt-Ser473 by peroxynitrite
and BDNF (50 ng/mL) was additive.
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phosphorylation of Akt was consequence of either the
nitrating or the oxidizing effect of PN in primary neurons.
This was performed with using ())-epicatechin, an anti-
oxidant compound known to differentially prevent nitration
and oxidation by PN (Schroeder et al. 2001). To validate
the efficacy of this compound under our experimental
conditions, we incubated neurons with PN in the presence
of increasing concentrations of epicatechin. Then, we
determined the oxidation of the fluorescent probe H2DCFA
and the presence of nitrated proteins in the same cells. As
shown in Fig. 4a, 100 lmol/L epicatechin prevented protein
nitration (upper panel) without altering oxidation (lower
panel) by PN; however, 1000 lmol/L epicatechin prevented
both nitration and oxidation. Using an identical experimen-
tal protocol, we then investigated whether epicatechin was
able to alter the neuroprotective effect of PN. As shown in
Fig. 4b, PN prevented etoposide-mediated apoptotic death
at 100 lmol/L, but not at 1000 lmol/L, epicatechin. In
addition, we found that PN phosphorylated Akt-Ser473 at
100 lmol/L, but not at 1000 lmol/L, epicatechin (Fig. 4c).
We also observed that epicatechin decreased Akt-Ser473
phosphorylation in control (degraded PN-treated) neurons
(Fig. 4c), suggesting that epicatechin might directly affect
the ability of Akt to be phosphorylated. To test this
possibility, neurons were subjected to BDNF-mediated Akt-
Ser473 phosphorylation in the presence of increasing
concentrations of epicatechin. As depicted in Fig. 4d,
epicatechin was unable to prevent BDNF-mediated Akt-
Ser473 phosphorylation. Together, these results suggest that
neuroprotection and Akt phosphorylation were due to the
oxidizing, not nitrating, effect of PN.
Peroxynitrite oxidizes phosphoinositide phosphatase and
prevents the excess apoptotic death caused by PTEN
over-expression in primary neurons
In view that Akt phosphorylation and neuroprotection exerted
by PN were not due to the upstream activation of the Trk-
PI3K/Akt pathway, we wondered whether those effects
were related to the impairment of Akt dephosphorylation.
Akt is an anti-apoptotic kinase that is activated by phos-
phorylation, promoted by phosphatidylinositol-dependent
kinase 1 (PDK1), a kinase that is in turn activated by the
effector phosphatidyl-inositol-3,4,5-trisphosphate (PIP3), i.e.
the product of PI3K activity. PTEN is the phosphatase that
eliminates the 3-phosphate of PIP3, antagonizing PDK1-
mediated Ser473-Akt phosphorylation. Conversely, PTEN
(a) (b)
(c)
(d)
Fig. 4 Protein oxidation, but not nitration, accounts for the neuro-
protective effect of peroxynitrite. (a) Epicatechin prevented both
nitration (upper panel) and oxidation (lower panel) by peroxynitrite;
however, at 100 lmol/L, epicatechin prevented nitration, but not
oxidation, whereas at 1000 lmol/L it prevented both nitration and oxi-
dation. (b) Peroxynitrite prevented the apoptosis caused by etoposide
at 100 lmol/L, but not at 1000 lmol/L, epicatechin. (c) Peroxynitrite
phosphorylated Akt-Ser473 at 100 lmol/L, but not at 1000 lmol/L,
epicatechin. (d) Epicatechin does not interfere with BDNF (50 ng/mL)-
mediated Akt-Ser473 phosphorylation. *p < 0.05 when compared with
the corresponding control (degraded PN) values.
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inhibition, or mutation, impairs PIP3 inactivation, thus
enhancing the Akt-mediated anti-apoptotic pathway (Cully
et al. 2006). To address the possible role of PN on this PI3K-
PTEN network, we first investigated whether PN altered the
redox status of PTEN, a mechanism reported to regulate its
activity (Kwon et al. 2004). PTEN contains a critical Cys124
residue that is essential for the correct protein folding and
enzyme activity (Lee et al. 2002; Kwon et al. 2004).
Oxidation of PTEN hence inhibits its activity. To ascertain
whether PN altered the redox status of PTEN, we performed
western blotting under non-reducing conditions in protein
extracts obtained from PN-treated primary neurons. As shown
in Figs 5a and b, PN or SIN-1 rapidly (5 or 15 min,
respectively) oxidized PTEN along with Akt phosphoryla-
tion. Furthermore, H2O2, which is well known to promote
PTEN oxidation (Lee et al. 2002) (Figs 5a and b), also
triggered Akt phosphorylation in primary neurons. These
results suggest that oxidation of PTEN by PN can account for
the rapid increase of Akt-Ser473 phosphorylation. Finally, we
aimed to elucidate whether PTEN oxidation by PN was
responsible for its neuroprotective properties. To accomplish
this, we over-expressed the full-length PTEN cDNA
(Fig. 5c), or its inactive form carrying a Cys124 fi Ser124
mutation in cortical neurons. As shown in Fig. 5d, transfec-
tion of primary neurons with wild type PTEN spontane-
ously (after 18 h) elicited apoptotic death; however,
transfection of neurons with the mutated form did not elicit
apoptotic death when compared with neurons expressing the
empty vector (pIRES) (Figs 5d and e). Interestingly, incuba-
tion of neurons with PN or SIN-1 (5 or 15 min, respectively),
(a)
(c)
(b)
(d) (e)
Fig. 5 Peroxynitrite oxidizes phosphatase with tensin homology
(PTEN) and prevents apoptotic death caused by PTEN over-expres-
sion in primary neurons. (a) Incubation of neurons with peroxynitrite
promoted the appearance of oxidized forms of PTEN, as judged by
western blotting under non-reducing conditions. H2O2 and glutathione
ethyl-ester (GSH) were used as controls for strong oxidizing- and
strong-reducing conditions, respectively. Oxidation of PTEN was
associated with Akt Ser473 phosphorylation. (b) PTEN oxidation by
peroxynitrite was confirmed using SIN-1 (0.5 mmol/L; 15 min). (c)
HEK293T cells were transfected with a cDNA encoding wild type
PTEN to confirm protein expression (upper panel). Transfection of
neurons in primary culture with wild type (wt) PTEN significantly
increased, 18 h later, apoptotic death when compared with transfec-
tions with either the empty vector (pIRES) or the mutated (mut,
Cys124 fi Ser124) form of PTEN. (d and e), This effect was prevented
by incubating neurons with peroxynitrite (5 min, d) or SIN-1 (15 min, e)
1 h before apoptotic death assessments. *p < 0.05 when compared
with the empty vector (pIRES) or mutated PTEN values. #p < 0.05
when compared with the corresponding control (degraded PN) value.
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1 h before apoptotic death assessments, prevented the
apoptotic death caused by over-expression of the wild type
PTEN, but did not alter the response to expression of the
mutated form (Figs 5d and e).
Discussion
Here we show that incubation of primary cortical neurons in
culture with PN – either authentic or formed from nitric
oxide and superoxide – rapidly triggers phosphorylation of
Akt at Ser473 and protects neurons against the apoptotic death
caused by etoposide. Such effects were abolished by
inhibition of PI3K activity with wortmannin, or by Akt
shRNA knock down, suggesting that PI3K/Akt pathway
mediated the anti-apoptotic effect of PN. Moreover, glutam-
ate receptor stimulation, in conditions known to elicit PN
formation (32, 39), caused Akt-Ser473 phosphorylation;
conversely, shRNA-mediated Akt knockdown promoted
apoptotic death. Together, these results strongly suggest that
PN can act as a signaling molecule capable of activating the
anti-apoptotic PI3K/Akt pathway in neurons.
In principle, our resultsmight be similar to those obtained by
other laboratories, which reported that PN promoted Akt-
Ser473 phosphorylation in human skin fibroblasts (Klotz et al.
2000). However, the latter study did not contemplate the
potential cell death/survival relevance of these findings, and
the mechanism suggested for Akt-Ser473 phosphorylation is
different from the onewe found. Thus, we demonstrate that PN
promoted Akt-Ser473 phosphorylation without altering the
phosphorylation status of TrkB, an endogenous anti-apoptotic
tyrosine kinase receptor for cortical neurons (Hetman et al.
1999). In other cellular systems, it has been reported that PN
oxidized protein–tyrosine–phosphatases (PTP) leading to the
inhibition of receptor tyrosine kinase dephosphorylation
(Mallozzi et al. 1997; Takakura et al. 1999; Klotz et al.
2002). In addition, it has been suggested that pre-treatment of
human skin fibroblasts with PN impairs subsequent PDGF-
induced phosphorylation of its cognate tyrosine kinase recep-
tor (Klotz et al. 2000). In contrast, we show that PN and the
endogenous TrkB ligand, BDNF, enhance, in an additive
fashion, Akt-Ser473 phosphorylation. This is consistent with
the notion that PN and BDNF act on different pathways
converging in PI3K/Akt activation, in cortical neurons.
Here we show that both, PN-mediated Akt-Ser473 phos-
phorylation and anti-apoptotic effects were due to its
oxidizing potential, and that these phenomena were closely
associated with PTEN oxidation. This raises the possibility
that our findings could also be attributable to other oxidizing
species formed during PN degradation (e.g. hydroxyl
radical), or formation from SIN-1 or glutamate (e.g. super-
oxide). Besides this, over-expression of the wild type PTEN
in primary neurons significantly increased apoptotic
death when compared with the expression of the inactive,
Cys124 fi Ser124 mutated form, confirming the importance
of Cys124 residue for PTEN full activity (Lee et al. 2002;
Kwon et al. 2004). Moreover, we show that incubation of
wild type PTEN-transfected neurons with PN prevented the
excess PTEN-induced apoptotic death. Together, these
results indicate that PN – and/or any of its related oxidizing
species – oxidizes PTEN, possibly at Cys124, hence impair-
ing PTEN to fold properly to acquire its full activity (Lee
et al. 2002). Interestingly, inhibition of the pro-apoptotic
function of PTEN by genetic mutations is known to increase
proliferation and the probability of tumorigenesis in certain
cycling cells (Lee et al. 2002; Cully et al. 2006). However,
the neurons used in this study are post-mitotic (Almeida
et al. 2005), making it unlikely that PTEN inhibition by PN
could cause increased proliferation. Rather, the anti-apoptotic
effect caused by PN-mediated inhibition of PTEN would
likely be associated with neuroprotection.
The notion that PN would exert neuroprotection is not in
disagreement with the results of other groups (Keynes et al.
2004) that have reported the high resistance of neurons
against glutamate. We provide a mechanistic explanation for
this phenomenon based on the activation of the PI3K/Akt
pathway, since Akt knockdown enhanced neuronal vulner-
ability to glutamate. We are aware that the neuroprotective
role that we herein propose for PN argues against the
widely held notion that it would be the neurotoxic NO-
derivative (Dawson et al. 1991). Relatively high concen-
trations of PN acutely applied to cell cultures and
mitochondrial preparations cause oxidation and/or nitration
of the complexes of the mitochondrial respiratory chain
(Bolan˜os et al. 1995), presumably leading to a loss of
function and neurodegeneration. Moreover, it has been
recently reported that PN (0.5 mmol/L)-induced apoptosis
of PC12 cells was associated with dephosphorylation –
leading to inactivation – of Akt (Shacka et al. 2006), a
result that might be in contradiction with our work.
However, it should be mentioned that Akt phosphorylation
was assessed, in such study, 16 h after PN additions
(Shacka et al. 2006). In contrast, we examined Akt
phosphorylation 5 min after PN exposure, and neuronal
viability within 1 h, a fact that might explain the discrep-
ancy. On the other hand, 3-nitrotyrosine immunostaining
has been found in human post-mortem brain sections of
patients that suffered from neurodegenerative diseases, such
as Alzheimer’s disease, suggesting PN formation (Bolan˜os
et al. 1997; Sultana et al. 2006). However, it has been
questioned whether oxidative –and nitrosative-stress is
cause, or consequence, of neurodegeneration (Andersen
2004). In view of these considerations and, in light of our
findings, it is tempting to suggest that PN formation would
represent an early anti-apoptotic cell response aimed at
avoiding the propagation of neurodegeneration. Furthermore,
our results support the recently highlighted notion (Zhu
et al. 2006) that PTEN may be a molecular target for
interfering with neurodegenerative diseases.
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